Publications

Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics 2014;133:e513-9. [Abstract]

Pobre K, Tashani M, Ridda I, Rashid H, Wong M, Booy R. Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines. Vaccine 2014;32:1423-30. [Abstract]

Chiew M, Gidding HF, Dey A, Wood J, Martin N, Davis S, McIntyre P. Estimating the measles effective reproduction number in Australia from routine notification data. Bulletin of the World Health Organization 2014;92:171-7. [Abstract]

Ridda I, Gao Z, Macintyre CR. Attitudes, knowledge and perceptions towards whooping cough and pertussis vaccine in hospitalized adults. Vaccine 2014;32:1107-12. [Abstract]

Beard FH, Macartney KK. Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG? [letter] . Medical Journal of Australia 2014;200:149.. [Abstract]

Crawford NW, Clothier H, Hodgson K, Selvaraj G, Easton ML, Buttery JP. Active surveillance for adverse events following immunization. Expert Review of Vaccines 2014;13:265-76 . [Full text]

Newall AT, Reyes JF, Wood JG, McIntyre P, Menzies R, Beutels P. Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses. Vaccine 2014;32:759-65 . [Abstract]

Menzies RI, Jayasinghe SH, Krause VL, Chiu CK, McIntyre PB. Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older. Medical Journal of Australia 2014;200:112-5. [Abstract]

Hull BP. Australian childhood immunisation coverage, 1 January to 31 March cohort, assessed as at 30 June 2013 [quarterly report] . Communicable Diseases Intelligence 2013;37:E434-5. [Full text]

Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2011 . Communicable Diseases Intelligence 2013;37:E291-312. [Full text]